These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT₇ receptor antagonist activity. Volk B; Gacsályi I; Pallagi K; Poszávácz L; Gyönös I; Szabó E; Bakó T; Spedding M; Simig G; Szénási G J Med Chem; 2011 Oct; 54(19):6657-69. PubMed ID: 21859099 [TBL] [Abstract][Full Text] [Related]
46. Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines. Mahé C; Bernhard M; Bobirnac I; Keser C; Loetscher E; Feuerbach D; Dev KK; Schoeffter P Br J Pharmacol; 2004 Oct; 143(3):404-10. PubMed ID: 15339860 [TBL] [Abstract][Full Text] [Related]
47. Emerging opportunities and concerns for drug discovery at serotonin 5-HT2B receptors. Brea J; Castro-Palomino J; Yeste S; Cubero E; Párraga A; Domínguez E; Loza MI Curr Top Med Chem; 2010; 10(5):493-503. PubMed ID: 20166944 [TBL] [Abstract][Full Text] [Related]
48. The extracellular entrance provides selectivity to serotonin 5-HT7 receptor antagonists with antidepressant-like behavior in vivo. Medina RA; Vázquez-Villa H; Gómez-Tamayo JC; Benhamú B; Martín-Fontecha M; de la Fuente T; Caltabiano G; Hedlund PB; Pardo L; López-Rodríguez ML J Med Chem; 2014 Aug; 57(15):6879-84. PubMed ID: 25073094 [TBL] [Abstract][Full Text] [Related]
49. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group. Hayat F; Cho S; Rhim H; Indu Viswanath AN; Pae AN; Lee JY; Choo DJ; Choo HY Bioorg Med Chem; 2013 Sep; 21(17):5573-82. PubMed ID: 23810425 [TBL] [Abstract][Full Text] [Related]
50. Benzimidazole derivatives. 2. Synthesis and structure-activity relationships of new azabicyclic benzimidazole-4-carboxylic acid derivatives with affinity for serotoninergic 5-HT(3) receptors. López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada ID; Orensanz L; Alfaro MJ; Martín MI J Med Chem; 1999 Dec; 42(24):5020-8. PubMed ID: 10585211 [TBL] [Abstract][Full Text] [Related]
51. Benzimidazole derivatives. 3. 3D-QSAR/CoMFA model and computational simulation for the recognition of 5-HT(4) receptor antagonists. López-Rodríguez ML; Murcia M; Benhamú B; Viso A; Campillo M; Pardo L J Med Chem; 2002 Oct; 45(22):4806-15. PubMed ID: 12383006 [TBL] [Abstract][Full Text] [Related]
53. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols. Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920 [TBL] [Abstract][Full Text] [Related]
54. Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors. Janoshazi A; Deraet M; Callebert J; Setola V; Guenther S; Saubamea B; Manivet P; Launay JM; Maroteaux L Mol Pharmacol; 2007 Jun; 71(6):1463-74. PubMed ID: 17325130 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT(6) receptor antagonists. Nirogi RV; Daulatabad AV; Parandhama G; Mohammad S; Sastri KR; Shinde AK; Dubey PK Bioorg Med Chem Lett; 2010 Aug; 20(15):4440-3. PubMed ID: 20594839 [TBL] [Abstract][Full Text] [Related]
56. Exogenous serotonin regulates proliferation of interstitial cells of Cajal in mouse jejunum through 5-HT2B receptors. Wouters MM; Gibbons SJ; Roeder JL; Distad M; Ou Y; Strege PR; Szurszewski JH; Farrugia G Gastroenterology; 2007 Sep; 133(3):897-906. PubMed ID: 17854596 [TBL] [Abstract][Full Text] [Related]
57. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat. Watts SW; Thompson JM J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222 [TBL] [Abstract][Full Text] [Related]
58. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes. Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750 [TBL] [Abstract][Full Text] [Related]
59. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis. Wang YQ; Lin WW; Wu N; Wang SY; Chen MZ; Lin ZH; Xie XQ; Feng ZW Acta Pharmacol Sin; 2019 Sep; 40(9):1138-1156. PubMed ID: 30814658 [TBL] [Abstract][Full Text] [Related]